Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (U54NS079202)
National Institute of General Medical Sciences (T32GM099608)
Article History
Received: 16 June 2017
Accepted: 5 October 2017
First Online: 16 October 2017
Compliance with ethical standards
:
: This work was supported by the CounterACT Program, National Institutes of Health Office of the Director, and the National Institute of Neurological Disorders and Stroke [U54NS079202]. Brandon Pressly was supported by a National Institute of General Medical Sciences funded Pharmacology Training Program [T32GM099608].